What Analyst Projections for Key Metrics Reveal About UnitedHealth (UNH) Q3 Earnings

23.10.25 15:15 Uhr

Werte in diesem Artikel
Aktien

309,90 EUR 0,20 EUR 0,06%

Indizes

PKT PKT

46.755,3 PKT 164,9 PKT 0,35%

17.984,8 PKT -24,4 PKT -0,14%

3.366,5 PKT 19,7 PKT 0,59%

6.742,4 PKT 43,0 PKT 0,64%

The upcoming report from UnitedHealth Group (UNH) is expected to reveal quarterly earnings of $2.80 per share, indicating a decline of 60.8% compared to the year-ago period. Analysts forecast revenues of $113.38 billion, representing an increase of 12.5% year over year.The consensus EPS estimate for the quarter has undergone a downward revision of 1.3% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.In light of this perspective, let's dive into the average estimates of certain UnitedHealth metrics that are commonly tracked and forecasted by Wall Street analysts.The combined assessment of analysts suggests that 'Revenues- Products' will likely reach $13.82 billion. The estimate indicates a change of +9.5% from the prior-year quarter.The average prediction of analysts places 'Revenues- Services' at $9.39 billion. The estimate suggests a change of +3.1% year over year.According to the collective judgment of analysts, 'Revenues- Premiums' should come in at $89.10 billion. The estimate indicates a year-over-year change of +15.1%.The consensus estimate for 'Revenues- Investment and other income' stands at $1.09 billion. The estimate points to a change of -33.5% from the year-ago quarter.Analysts predict that the 'Operating Statistics - Medical Care Ratio' will reach 90.8%. The estimate is in contrast to the year-ago figure of 85.2%.Analysts' assessment points toward 'UnitedHealthcare Customer Profile - People Served - Commercial - Domestic - Risk-based' reaching 8.45 million. Compared to the current estimate, the company reported 8.90 million in the same quarter of the previous year.Analysts expect 'UnitedHealthcare Customer Profile - People Served - Commercial - Domestic - Fee-based' to come in at 21.56 million. The estimate compares to the year-ago value of 20.83 million.It is projected by analysts that the 'UnitedHealthcare Customer Profile - People Served - Total Community and Senior' will reach 20.33 million. The estimate is in contrast to the year-ago figure of 19.60 million.Analysts forecast 'UnitedHealthcare Customer Profile - People Served - Community and Senior - Medicare Advantage' to reach 8.44 million. Compared to the current estimate, the company reported 7.81 million in the same quarter of the previous year.The consensus among analysts is that 'UnitedHealthcare Customer Profile - People Served - Community and Senior - Medicaid' will reach 7.59 million. The estimate is in contrast to the year-ago figure of 7.45 million.Based on the collective assessment of analysts, 'UnitedHealthcare Customer Profile - People Served - Community and Senior - Medicare Supplement (Standardized)' should arrive at 4.30 million. Compared to the current estimate, the company reported 4.34 million in the same quarter of the previous year.The collective assessment of analysts points to an estimated 'UnitedHealthcare Customer Profile - People Served - Medicare Part D stand-alone' of 2.77 million. The estimate compares to the year-ago value of 3.06 million. View all Key Company Metrics for UnitedHealth here>>> Shares of UnitedHealth have demonstrated returns of +2.8% over the past month compared to the Zacks S&P 500 composite's +0.2% change. With a Zacks Rank #2 (Buy), UNH is expected to beat the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .Radical New Technology Could Hand Investors Huge GainsQuantum Computing is the next technological revolution, and it could be even more advanced than AI.While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.See Top Quantum Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: UnitedHealth und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf UnitedHealth

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf UnitedHealth

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu UnitedHealth Inc.

Wer­bung

Analysen zu UnitedHealth Inc.

DatumRatingAnalyst
14.04.2022UnitedHealth OutperformRBC Capital Markets
15.10.2020UnitedHealth OutperformCredit Suisse Group
14.10.2020UnitedHealth OutperformRBC Capital Markets
29.08.2019UnitedHealth OutperformCredit Suisse Group
17.07.2018UnitedHealth buyGoldman Sachs Group Inc.
DatumRatingAnalyst
14.04.2022UnitedHealth OutperformRBC Capital Markets
15.10.2020UnitedHealth OutperformCredit Suisse Group
14.10.2020UnitedHealth OutperformRBC Capital Markets
29.08.2019UnitedHealth OutperformCredit Suisse Group
17.07.2018UnitedHealth buyGoldman Sachs Group Inc.
DatumRatingAnalyst
09.11.2016UnitedHealth Group NeutralMizuho
31.03.2011UnitedHealth Group performOppenheimer & Co. Inc.
08.02.2011UnitedHealth Group neutralGoldman Sachs Group Inc.
15.11.2010UnitedHealth Group holdStifel, Nicolaus & Co., Inc.
20.04.2010UnitedHealth neutralWedbush Morgan Securities Inc.
DatumRatingAnalyst
11.06.2009UnitedHealth underperformOppenheimer & Co. Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für UnitedHealth Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen